Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
---|---|---|---|
6/30/2025 | $ -33.55M | $ 6.79M | -4.94 |
3/31/2025 | $ -38.96M | $ 6.23M | -6.25 |
12/31/2024 | $ -41.51M | $ 5.54M | -7.49 |
9/30/2024 | $ -40.41M | $ 4.66M | -8.67 |
6/30/2024 | $ -43.9M | $ 4M | -10.97 |
3/31/2024 | $ -41.26M | $ 3.38M | -12.19 |
12/31/2023 | $ -41.89M | $ 2.79M | -15 |
9/30/2023 | $ -43.07M | $ 2.25M | -19.12 |
6/30/2023 | $ -38.19M | $ 1.69M | -22.63 |
3/31/2023 | $ -39.1M | $ 1.27M | -30.89 |
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for GALECTIN THERAPEUTICS INC is calculated as follows: EBIT [ $ -20.66M ] / Int. Exp. [ $ 87K ]
(=) Int. Coverage [ -237.51 ]
Minimum
Mar 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 2.37K |
---|---|
min | -25.49 |
max | 28.75 |
average | 2.16 |
median | 2.09 |
std | 8.45 |